Paracetamol/ Ascorbic Acid/ Diphenhydramine/ Phenylephrine
Indications
Registered South African indications:
- Colds and flu
Cautions
Combination products may have additional pharmacological effects not accounted for by the action of the individual ingredients
Paracetamol
Contraindications
- Hypersensitivity to the active ingredient or any of the excipients in this combination product
- Severe hepatic impairment
Cautions
- Pregnancy
- Renal impairment
- Mild to moderate hepatic impairment
Ascorbic acid
Contraindications
- Hypersensitivity to the active ingredient or any of the excipients in this combination product
- Hyperoxaluria
Cautions
- Pregnancy
- Breastfeeding
- Renal impairment
- Diabetes mellitus
- Glucose-6-phosphate dehydrogenase deficiency
- Haemachromatosis
- High doses
Diphenhydramine
Contraindications
- Hypersensitivity to the active ingredient or any of the excipients in this combination product
- Asthma
- Narrow angle glaucoma
- Prostatic hypertrophy
- Stenosing peptic ulcer
- Pyloroduodenal obstruction
- Bladder neck obstruction
- Porphyria
Cautions
- Breastfeeding
- Moderate to severe renal impairment
- Hepatic impairment
- Elderly
- Glaucoma
- Urinary retention
- Myasthenia gravis
- Epilepsy
- Bronchitis
- Chronic obstructive pulmonary disease
- Tinnitus
- Prolonged use
Phenylephrine
Contraindications
- Hypersensitivity to the active ingredient or any of the excipients in this combination product
- Cardiovascular disease
- Hypertension
- Diabetes mellitus
- Closed angle glaucoma
- Hyperthyroidism
- Prostatic hypertrophy
- Phaeochromocytoma
- Coadministration with monoamine oxidase inhibitors or within 14 days of use
Cautions
- Pregnancy
- Breastfeeding
- Occlusive vascular disease
- Prolonged use
Adult dosage
Forms avail. in SA and covered in this monograph: cap
Symptomatic relief of colds and influenza
Paracetamol/ Ascorbic acid/ Diphenhydramine/ Phenylephrine
400/50/10/5 (mg)
- Oral (cap): 1-2 cap, 4-6hrly; Max: 8 cap/24hrs
Paediatric dosage
Paed. forms avail. in SA and covered in this monograph: cap
Symptomatic relief of colds and influenza
Paracetamol/ Ascorbic acid/ Diphenhydramine/ Phenylephrine
400/50/10/5 (mg)
Younger than 12 years
- Not established for use
Older than 12 years
- See adult dosage
Special populations
Recommendations for this combination product as per highest risk category when comparing individual active ingredients
Pregnancy
Breastfeeding
Renal Impairment
Hepatic Impairment
- Mild to moderate: Caution; no dose adjustment recommended (Paracetamol)
- Severe: Contraindicated (Paracetamol)
Elderly
Drugs in Sport
- Permitted - No warning
Adverse reactions
Combination products may have additional pharmacological effects not accounted for by the action of the individual ingredients
Paracetamol
Respiratory Disorders
- Bronchospasm
Hepatobiliary Disorders
- Hepatic dysfunction
Immune, Blood and Lymphatic System Disorders
- Anaphylaxis
- Cutaneous hypersensitivity reactions
- Angioedema
- Stevens Johnson syndrome
- Thrombocytopenia
- Agranulocytosis
- Methaemoglobinaemia
Ascorbic acid
Central Nervous System Disorders
- Dizziness
- Fatigue
- Headache
Cardiovascular Disorders
- Flushing
Gastrointestinal Disorders
- Diarrhoea
- Nausea and vomiting
- Flank pain
- Heartburn
Endocrine and Metabolic Disorders
- Hyperoxaluria
Diphenhydramine
Central Nervous System Disorders
- Sedation
- Disturbances in attention
- Unsteadiness
- Dizziness
- Seizures
- Headache
- Paraesthesia
- Dyskinesias
- Fatigue
- Confusion
- Paradoxical excitement
Cardiovascular Disorders
- Tachycardia
- Palpitations
Respiratory Disorders
- Dyspnoea
- Thickening of bronchial secretions
Gastrointestinal Disorders
- Dry mouth
- Nausea and vomiting
Genitourinary Disorders
- Urinary difficulty
- Urinary retention
Musculoskeletal Disorders
- Muscle twitching
Immune, Blood and Lymphatic System Disorders
- Hypersensitivity reactions
- Urticaria
- Angioedema
Sensory Disorders
- Blurred vision
- Tinnitus
Phenylepherine
Central Nervous System Disorders
- Headache
Cardiovascular Disorders
- Tachycardia
- Cardiac arrhythmia
- Palpitations
- Hypertension
Gastrointestinal Disorders
- Nausea and vomiting
Genitourinary Disorders
- Urinary retention
Interactions
Combination products may have additional pharmacological effects not accounted for by the action of the individual ingredients
Paracetamol
- Metoclopramide
- Domperidone
- Cholestyramine
- Oral anticoagulants
- Chloramphenicol
Ascorbic acid
- Bortezomib
- Fluphenazine
- Desferoxamine
- Copper
- Aluminium
- Aspirin
- Nicotine
- Alcohol
- Appetite suppressants
- Anticonvulsants
- Iron
- Oral contraceptives
- Tetracycline
- Oral anticoagulants
- Citrate
Diphenhydramine
- Central nervous system depressants
- Monoamine oxidase inhibitors
- Anticholinergic agents
- CYP2D6 substrates
Phenylephrine
- Monoamine oxidase inhibitors
- Anticholinergic agents
- Digoxin
- Sympathomimetic agents
- Tricyclic antidepressants
- Vasodilating agents
- Beta blockers
- CYP450 inducers
- Linezolid
- Alcohol
Monitoring
None routine
Mechanism of action
Paracetamol
Paracetamol increases the pain threshold by inhibiting both isoforms of cyclooxygenase, COX-1, COX-2, and COX-3 enzymes involved in prostaglandin synthesis. It does not inhibit cyclooxygenase in peripheral tissues and, thus, has no peripheral anti-inflammatory affects.
Ascorbic acid
Ascorbic acid, a water-soluble vitamin, is essential for formation of collagen and intercellular material, and therefore necessary for the development of cartilage, bone, teeth and for the healing of wounds. It is also essential for the conversion from folic acid to folinic acid, facilitates iron absorption from the gastro-intestinal tract, influences haemoglobin formation and erythrocyte maturation and assists in providing resistance to infections.
Diphenhydramine
Diphenhydramine is a histamine H1-receptor antagonist that competes with free histamine for binding at histamine receptors. In addition to its usual anti-allergy actions, it also has significant sedative and antimuscarinic properties.
Phenylephrine
Phenylephrine is a sympathomimetic agent which acts directly on adrenoreceptors. It has predominantly alpha adrenergic activity and does not cause stimulation of the central nervous system. It produces vasoconstriction which relieves nasal congestion.
Dosage forms
- Capsule
Formulation
COMBINATION PREPARATIONS
Paracetamol/ Ascorbic acid/ Diphenhydramine/ Phenylephrine
Capsule 400mg/50mg/10mg/5mg
- Fluend (Akacia)
References
1. https://drive.google.com/drive/folders/19g_ZE8Lx91C2_GPtd-HP_DDyzVJTrjV0 (07/06/2017_Mims_Fluend_caps) 2. https://drive.google.com/drive/folders/19g_ZE8Lx91C2_GPtd-HP_DDyzVJTrjV0 (08/1977_Alliance_Fluend_caps) **No SPC available See individual monographs -https://admin.emguidance.com/medicine-edit/2cf8920b-6c41-40de-b3ed-65bc5778f068 -https://admin.emguidance.com/medicine-edit/5ad999b9-bd8b-45b6-80db-931ccd94f71a -https://admin.emguidance.com/medicine-edit/9ebe5ad3-5c86-498f-9da5-98d804f45699 -https://admin.emguidance.com/medicine-edit/bb81be1c-49cd-45e9-aada-b6b48a11d4d0 no uptodate
Brands & products
2 products · cached snapshot- Fluend
CAPCapsule· 2 products
from R23.57| Product | Strength | Pack | Applicant | Min price |
|---|---|---|---|---|
| Fluend | 400 mg;mg;mg;mg | 20 | Akacia Health Care (Pty) Ltd | R23.57 |
| Fluend | 400 mg;mg;mg;mg | 1000 | Akacia Health Care (Pty) Ltd | R1179.63 |
Medical aid coverage
data not yet integrated- Comprehensive Series—
- Executive Plan—
- KeyCare Series—
- Priority Series—
- Saver Series—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- BonClassic—
- BonComprehensive—
- BonEssential—
- BonFit Select—
- BonSave—
- BonStart—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Beryl—
- Emerald—
- Onyx—
- Ruby—
- Sapphire—
- Tanzanite One—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Aquarium Option—
- Efficiency Option—
- Marine Option—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.